×

J DIABETES INVEST 2020 10.1111/jdi.13455
Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease
Yoo1, JH; Kang, M; Kim, G; Hur, KY; Kim, JH; Sinn, DH; Jin, SM

AM J TRANSPLANT 2020 10.1111/ajt.16323
Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation
Kim1, G; Lee, HS; Oh, BJ; Kwon, Y; Kim, H; Ha, S; Jin, SM; Kim, JH

J DIABETES INVEST 2020 10.1111/jdi.13384
East Asian diet-mimicking diet plan based on the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet in adults with type 2 diabetes A randomized controlled trial
Jin1, SM; Ahn, J; Park, J; Hur, KY; Kim, JH; Lee, MK

BMC MED INFORM DECIS MAK 2020 10.1186/s12911-020-01179-x
Validation of the effectiveness of a digital integrated healthcare platform utilizing an AI-based dietary management solution and a real-time continuous glucose monitoring system for diabetes management a randomized controlled trial
Park1, SW; Kim, G; Hwang, YC; Lee, WJ; Park, H; Kim, JH

DIABETES TECHNOL THE 2020 10.1089/dia.2019.0499
Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
Yoo1, JH; Choi, MS; Ahn, J; Park, SW; Kim, Y; Hur, KY; Jin, SM; Kim, G; Kim, JH

Diabetes Metab J 2020 10.4093/dmj.2020.0080
An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment (Diabetes Metab J 2020;44:56-66)
Park1, SW; Lee, S; Cha, WC; Hur, KY; Kim, JH; Lee, MK; Park, SM; Jin, SM

ENDOCRINOL METAB 2020 10.3803/EnM.2020.35.1.1
Impact of Skeletal Muscle Mass on Metabolic Health
Kim1, G; Kim, JH

Diabetes Metab J 2020 10.4093/dmj.2018.0227
An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment
Park1, SW; Lee, S; Cha, WC; Hur, KY; Kim, JH; Lee, MK; Park, SM; Jin, SM

DIABETES-METAB RES 2019 10.1002/dmrr.3197
Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome
Lee1, YB; Han, K; Kim, B; Jun, JE; Lee, SE; Ahn, J; Kim, G; Jin, SM; Kim, JH

BMC CANCER 2019 10.1186/s12933-019-0953-7
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
Lee1, YB; Han, K; Kim, B; Lee, SE; Jun, JE; Ahn, J; Kim, G; Jin, SM; Kim, JH

DIABETES-METAB RES 2019 10.1002/dmrr.3197
Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome
Lee1, YB; Han, K; Kim, B; Jun, JE; Lee, SE; Ahn, J; Kim, G; Jin, SM; Kim, JH

BIOMATERIALS 2019 10.1016/j.biomaterials.2019.119224
Multi-layer surface modification of pancreatic islets for magnetic resonance imaging using ferumoxytol
Jin1, SM; Lee, HS; Haque, MR; Kim, HN; Kim, HJ; Oh, BJ; Lee, KW; Kim, G; Kim, HS; Lee, DY; Park, JB; Kim, SJ; Byun, Y; Kim, JH

DIABETES OBES METAB 2019 10.1111/dom.13882
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study)
Kwak1, SH; Hwang, YC; Won, JC; Bae, JC; Kim, HJ; Suh, S; Lee, EY; Lee, S; Kim, SY; Kim, JH

Diabetes Metab J 2019 10.4093/dmj.2018.0079
The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome
Yu1, TY; Jin, SM; Jee, JH; Bae, JC; Lee, MK; Kim, JH

Diabetes Metab J 2019 10.4093/dmj.2019.0137
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Kim1, MK; Ko, SH; Kim, BY; Kang, ES; Noh, J; Kim, SK; Park, SO; Hur, KY; Chon, S; Moon, MK; Kim, NH; Kim, SY; Rhee, SY; Lee, KW; Kim, JH; Rhee, EJ; Chun, S; Yu, SH; Kim, DJ; Kwon, HS; Park, KS

BRIT J NUTR 2019 10.1017/S0007114519001430
Circulating calcium levels and the risk of type 2 diabetes: a systematic review and meta-analysis
Zhu1, J; Xun, P; Bae, JC; Kim, JH; Kim, DJ; Yang, K; He, K

Diabetes Metab J 2019 10.4093/dmj.2018.0092
Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
Kang1, YM; Jung, CH; Lee, SH; Kim, SW; Song, KH; Kim, SG; Kim, JH; Cho, YM; Park, TS; Ku, BJ; Koh, G; Kim, DM; Lee, BW; Park, JY

KOREAN JOURNAL OF INTERNAL MEDICINE 2019 10.3904/kjim.2019.188
2018 Guidelines for the management of dyslipidemia
Rhee1, FJ; Kim, HC; Kim, JH; Lee, EY; Kim, BJ; Kim, EM; Song, Y; Lim, JH; Kim, HJ; Choi, S; Moon, MK; Na, JO; Park, KY; Oh, MS; Han, SY; Noh, J; Yi, KH; Lee, SH; Hong, SC; Jeong, IK

J BONE MINER METAB 2019 10.1007/s00774-018-0959-3
Change of skeletal muscle mass in patients with pheochromocytoma
Lee1, SH; Kwak, MK; Ahn, SH; Kim, H; Cho, YY; Suh, S; Song, KH; Koh, JM; Kim, JH; Kim, BJ

OSTEOPOROSIS INT 2019 10.1007/s00198-019-04871-5
The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism
Ahn1, SH; Kim, JH; Cho, YY; Suh, S; Kim, BJ; Hong, S; Lee, SH; Koh, JM; Song, KH

SURGERY 2019
Reply to letter to editor regarding: "A clinical prediction model to estimate the metastatic potential of Pheochromocytoma/paraganglioma: ASES score"
Cho1, YY; Kwak, MK; Lee, SE; Kim, JH; Lee, SH

Front Endocrinol (Lausanne) 2019 10.3389/fendo.2019.00195
The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex
Kwak1, MK; Lee, SE; Cho, YY; Suh, S; Kim, BJ; Song, KH; Koh, JM; Kim, JH; Lee, SH

CARDIOVASC DIABETOL 2019 10.1186/s12933-019-0830-4
Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus
Jun1, JE; Lee, SE; Choi, MS; Park, SW; Hwang, YC; Kim, JH

Diabetes Metab J 2019 10.4093/dmj.2018.0048
High Proportion of Adult Cases and Prevalence of Metabolic Syndrome in Type 1 Diabetes Mellitus Population in Korea: A Nationwide Study
Lee1, YB; Han, K; Kim, B; Jin, SM; Lee, SE; Jun, JE; Ahn, J; Kim, G; Kim, JH

Diabetes Metab Res Rev 2019 10.1002/dmrr.3092
Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes
Jun1, JE; Lee, SE; Lee, YB; Ahn, JY; Kim, G; Hur, KY; Lee, MK; Jin, SM; Kim, JH

STEM CELLS 2019 10.1002/stem.2920
A Subset of Paracrine Factors as Efficient Biomarkers for Predicting Vascular Regenerative Efficacy of Mesenchymal Stromal/Stem Cells
Kim1, HK; Lee, SG; Lee, SW; Oh, BJ; Kim, JH; Kim, JA; Lee, G; Jang, JD; Joe, YA

Diabetes Metab J 2018 10.4093/dmj.2018.0012
Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia
Lee1, YB; Jun, JE; Lee, SE; Ahn, J; Kim, G; Jee, JH; Bae, JC; Jin, SM; Kim, JH

HEPATOLOGY 2018 10.1002/hep.30049
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study
Kim1, G; Lee, SE; Lee, YB; Jun, JE; Ahn, J; Bae, JC; Jin, SM; Hur, KY; Jee, JH; Lee, MK; Kim, JH

ANN LAB MED 2018 10.3343/alm.2018.38.6.530
Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System
Oh1, J; Kim, JH; Park, HD